58 related articles for article (PubMed ID: 3778556)
1. Affinity of pyridylalkylamines for nicotinic, muscarinic and histaminic recognition sites in brain tissue preparations.
Repond C; Pratt JA; Stolerman IP; Mayer JM; Jenner P; Marsden CD; Testa B
Arzneimittelforschung; 1986 Aug; 36(8):1191-4. PubMed ID: 3778556
[TBL] [Abstract][Full Text] [Related]
2. Effect of piperidine and related alicyclic amines on nicotinic and muscarinic agonist binding sites in the mammalian brain.
Yamada S; Kagawa Y; Ushijima H; Takayanagi N; Hayashi E
J Pharmacobiodyn; 1986 Jul; 9(7):620-5. PubMed ID: 3772718
[TBL] [Abstract][Full Text] [Related]
3. Absence of an effect of terfenadine on guinea pig brain histamine H1-receptors in vivo determined by receptor binding techniques.
Wiech NL; Martin JS
Arzneimittelforschung; 1982; 32(9a):1167-70. PubMed ID: 6817763
[TBL] [Abstract][Full Text] [Related]
4. Effect of stimulation or inhibition of muscarinic or nicotinic receptors on the content of biogenic amines in various parts of rat brain.
Bień E; Herman ZS
Acta Physiol Pol; 1983; 34(2):227-32. PubMed ID: 6141700
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine.
Roth KA; McIntire SL; Barchas JD
J Pharmacol Exp Ther; 1982 May; 221(2):416-20. PubMed ID: 7077536
[TBL] [Abstract][Full Text] [Related]
6. Interaction of choline with nicotinic and muscarinic cholinergic receptors in the rat brain in vitro.
Costa LG; Murphy SD
Clin Exp Pharmacol Physiol; 1984; 11(6):649-54. PubMed ID: 6536422
[TBL] [Abstract][Full Text] [Related]
7. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
8. Non-ginsenoside nicotinic activity in ginseng species.
Lewis R; Wake G; Court G; Court JA; Pickering AT; Kim YC; Perry EK
Phytother Res; 1999 Feb; 13(1):59-64. PubMed ID: 10189953
[TBL] [Abstract][Full Text] [Related]
9. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
Waelbroeck M; Robberecht P; Chatelain P; Christophe J
Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116
[TBL] [Abstract][Full Text] [Related]
10. The effects of a new cholinolytic--8018--and its optical isomers on the central muscarinic and nicotinic receptors.
Niu WZ; Zhao DL; Liu CG
Arch Int Pharmacodyn Ther; 1990; 304():64-74. PubMed ID: 2241419
[TBL] [Abstract][Full Text] [Related]
11. Histamine H1-receptors in brain labeled with 3H-mepyramine.
Chang RS; Tran VT; Snyder SH
Eur J Pharmacol; 1978 Apr; 48(4):463-4. PubMed ID: 648590
[No Abstract] [Full Text] [Related]
12. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
13. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
Gurwitz D; Kloog Y; Sokolovsky M
Mol Pharmacol; 1985 Sep; 28(3):297-305. PubMed ID: 4033630
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
16. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.
Yeramian E; Garbarg M; Schwartz JC
Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
Vickroy TW; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
[TBL] [Abstract][Full Text] [Related]
18. Studies of muscarinic and nicotinic binding sites in brain.
Nordberg A; Larsson C
Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
[TBL] [Abstract][Full Text] [Related]
19. Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
Crooks PA; Ayers JT; Xu R; Sumithran SP; Grinevich VP; Wilkins LH; Deaciuc AG; Allen DD; Dwoskin LP
Bioorg Med Chem Lett; 2004 Apr; 14(8):1869-74. PubMed ID: 15050618
[TBL] [Abstract][Full Text] [Related]
20. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
